Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Appointments

Set Alert for Appointments

Executives On The Move: New CEOs At Alentis Therapeutics, Melinta Therapeutics And NBE-Therapeutics

New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.

Appointments BioPharmaceutical

Biotech Entrepreneur Aldag Inspired By Italy's Genespire

Jörn Aldag, who has over 20 years of leadership experience in the life sciences industry, including CEO of gene therapy pioneer uniQure, tells Scrip that the research carried at the world-class Italian research institute SR-Tiget.

Gene Therapy Appointments

Executives On The Move: New CEO Appointed At La Jolla Pharmaceutical, COO Named At Mesoblast

Also, NeuBase Therapeutics has secured a new chief operating officer and Amgen has named a new vice president-finance/chief accounting officer.

Appointments BioPharmaceutical

Executives On The Move: Sun BioPharma Gets New CEO And New CMOs at Innate Pharma And Biotron

AnaptysBio secures new chief financial officer, while Tarsus Pharmaceuticals has a new chief operating officer.

Appointments BioPharmaceutical

Executives On The Move: Kiadis, Oncologie and Atossa Therapeutics Fill Senior Positions

New chief medical officers take up positions at Abeona Therapeutics, Akcea Therapeutics and Oncologie, while there are new CFOs at Affimed, NGM Biopharmaceuticals, Phathom Pharmaceuticals, Oncologie and Syndax Pharmaceuticals.

Appointments BioPharmaceutical

Executives On The Move: New CEOs At Ipsen, Herantis Pharma And Oncopeptides

BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.

Appointments BioPharmaceutical

Executives On The Move: BioXcel Therapeutics Picks A Development Officer, A Finance Hire At RenovaCare And CANbridge Taps Takeda Talent

Immuno-oncology and neuroscience firm BioXcel Therapeutics picks a chief development officer, and stem-cell therapy company RenovaCare hires a CFO. Plus, CANbridge Life Sciences, developer of specialty health products, adds Takeda Pharma rare disease lead as global head, business development.

Appointments BioPharmaceutical

Executives On The Move: Boehringer Announces US Promotion, Immatics Chooses A CMO And DalCor Pharma Fills C-Suite Commercial Post

Boehringer Ingelheim announces its BI Pharma president to take helm from retiring US country managing director and chief executive officer. Immunotherapeutics developer Immatics Biotechnologies chooses GSK cell therapy head as CMO, and precision medicine firm DalCor Pharmaceuticals picks a chief commercial officer.

Appointments BioPharmaceutical

Executives On The Move: Clinical Positions Filled At Gilead, Sanifit and Spectrum, And Ferring Pharma US Officer Is Promoted

Anti-viral pharma Gilead Sciences, vascular calcification treatment firm Sanifit and hematology and oncology drug developer Spectrum Pharmaceuticals each select a new VP, clinical development. Also, to oversee its group in the US, multinational Ferring Pharmaceuticals promotes its US chief commercial officer to president.

Appointments BioPharmaceutical

Executives On The Move: Ipsen Decides On New Leader, A CSO for 4P-Pharma And A CFO During Transition for Histogen

Paris, France-based Ipsen decides on a Sanofi Pasteur exec for CEO and Roche Institute head joins cancer and inflammatory therapy company 4P-Pharma as CSO. Meanwhile, regenerative medicine firm Histogen brings on a new CFO during its transition to a public company.

Appointments BioPharmaceutical

Arix Assembles New Teams To Advance Portfolio

Arix Biosciences has unveiled three significant changes to the organization, including the appointment of Christian Schetter as co-managing director, which the healthcare-focused venture capitalist hopes will keep its impressive record of biotech investments on track.

Appointments Business Strategies

Executives On The Move: New CEOs At Cyxone And Innoviva, Promotions At Celyad

Exits from Pfizer and Gilead as executives move to Oligomerix Inc. and Pandion Therapeutics, respectively, while chief medical officers are appointed at Exicure and Larimar Therapeutics Inc.

Appointments BioPharmaceutical
See All
UsernamePublicRestriction

Register